Accumulated evidence indicated that the expression of decoy receptor 3 (DcR3), a secreted molecule, was positively correlated with the malignant process of pancreatic cancer and poor survival (57, 85). This evidence concerns the gene TNFRSF6B and familial pancreatic carcinoma.